Calming and Sleeping in France
In 2012, the preference for herbal and soft medicines, which emerged a few years ago, remained robust. French women, who account for more than 60% of total value sales (including Rx drugs) of calming and sleeping products in France, tend to favour softer drugs for calming and sleeping. On a more general level, there was also growing concern over potential addiction to standard/chemical drugs, as well as adverse secondary effects. The Mediator scandal in France accentuated such concerns amongst...
Euromonitor International's Calming and Sleeping in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Calming and Sleeping market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.